Xencor (XNCR) Free Cash Flow (2013 - 2026)
Xencor's (XNCR) quarterly Free Cash Flow came in at -$68.2 million in Q1 2026, down 286.31% year-on-year from $36.6 million in Q1 2025, and down 29.11% on a QoQ basis from -$52.9 million in Q4 2025.
Xencor (XNCR) Free Cash Flow (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Free Cash Flow data on file, last reported at -$68.2 million in Q1 2026.
- On a quarterly basis, Free Cash Flow fell 286.31% year-over-year to -$68.2 million in Q1 2026; TTM through Mar 2026 was -$188.8 million, a 11.77% decrease from a year earlier, with the FY2025 full-year figure at -$138.3 million, up 33.62% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$68.2 million, down from -$52.9 million in the prior quarter.
- Over the last five years, Free Cash Flow for XNCR reached as high as $31.9 million in Q2 2022 and fell as low as -$70.4 million in Q2 2024.
- Historically, Free Cash Flow has averaged -$30.9 million across 5 years, with a median of -$34.4 million in 2022.
- Across the five-year window, Free Cash Flow surged 367.36% in 2022 and sank 1211.03% in 2023, its largest moves.
- Year by year, Free Cash Flow stood at -$34.4 million in 2022, then soared by 149.97% to $17.2 million in 2023, then sank by 399.62% to -$51.5 million in 2024, then decreased by 2.62% to -$52.9 million in 2025, then dropped by 29.11% to -$68.2 million in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were -$68.2 million in Q1 2026, -$52.9 million in Q4 2025, and -$31.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | -68.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68.24 Mn |
| Mar 31, 2026 | -68.24 Mn |
| Dec 31, 2025 | -52.85 Mn |
| Dec 31, 2025 | -52.85 Mn |
| Sep 30, 2025 | -31.00 Mn |
| Sep 30, 2025 | -31.00 Mn |
| Jun 30, 2025 | -36.75 Mn |
| Jun 30, 2025 | -36.75 Mn |
| Mar 31, 2025 | -17.66 Mn |
| Mar 31, 2025 | -17.66 Mn |
| Dec 31, 2024 | -51.50 Mn |
| Dec 31, 2024 | -51.50 Mn |
| Sep 30, 2024 | -29.42 Mn |
| Sep 30, 2024 | -29.42 Mn |
| Jun 30, 2024 | -70.38 Mn |
| Jun 30, 2024 | -70.38 Mn |
| Mar 31, 2024 | -56.99 Mn |
| Mar 31, 2024 | -56.99 Mn |
| Dec 31, 2023 | 17.19 Mn |
| Dec 31, 2023 | 17.19 Mn |